Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience

BACKGROUND: Multiple myeloma (MM) constitutes approximately 10% of hematological malignancies. Bisphosphonates have established themselves in solid organ metastasis and multiple myeloma lytic bone lesions by inhibiting osteoclast activation. Medication-related osteonecrosis of the jaw (MRONJ) emerge...

Descripción completa

Detalles Bibliográficos
Autores principales: Taş Ozyurtseven, Betul, Serin, Istemi, Nursal, Ayse Feyda, Pehlivan, Sacide, Pehlivan, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130567/
https://www.ncbi.nlm.nih.gov/pubmed/34006261
http://dx.doi.org/10.1186/s12903-021-01634-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130567/
https://www.ncbi.nlm.nih.gov/pubmed/34006261
http://dx.doi.org/10.1186/s12903-021-01634-9

Ejemplares similares